International Association for the Study of Lung Cancer(IASLC) shared a post on LinkedIn:
“Registration and Abstract are now open for the IASLC HT26!
This year’s meeting will focus on resistance to immunotherapy, bringing together researchers and clinicians to explore the scientific mechanisms behind treatment resistance and the strategies being developed to overcome it.
Other articles about Lung Cancer on OncoDaily.